Abbvie Inc

NYSE:ABBV  
135.85
+2.33 (+1.74%)
4:42:59 PM EDT: $135.73 -0.12 (-0.09%)
Products

AbbVie Says RINVOQ Receives U.S. FDA Approval For Active Psoriatic Arthritis

Published: 12/14/2021 23:34 GMT
Abbvie Inc (ABBV) - Rinvoq® (upadacitinib) Receives U.S. FDA Approval for Active Psoriatic Arthritis.